Prucalopride

CAS 179474-81-8 1 current record 1 historicalSmall Molecule

Who holds supplier records for Prucalopride? 1 organisation holds a current record for Prucalopride: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (1).

Most records are filed under another form of this substance: Prucalopride Succinate (12 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Prucalopride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/prucalopride

Reading the evidence

  • One current record

    One organisation holds a current DMF or CEP. A record shows a regulatory filing, not current commercial availability or a qualified source for your product.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

Current records (1)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Prucalopride. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • Erythro Pharma Private Limited
    Active DMF 39188 · latest filing Jul 2024
    India
Need Prucalopride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Prucalopride are no longer active. These show a past filing, not current supply.

Show all 1 historical record

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (36 listed products contain Prucalopride). The latest listed exclusivity runs to 10 Jul 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Prucalopride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL117287).

Chemical identity

IUPAC name
4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide
Canonical SMILES
COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl
InChIKey
ZPMNHBXQOOVQJL-UHFFFAOYSA-N
Synonyms
Prucaloprida, Prucalopride, R-093877, R093877, Resolor, resotrans, prucalopridum, RefChem:57530, A06AX05, Prucalopride?, Prucalopride [USAN:INN:BAN], 179474-81-8 (free base)

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin-4 Receptor Agonist
Mechanism of action
Serotonin 4 Receptor Agonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Prucalopride?

1 organisation holds an active US FDA Type II Drug Master File or a CEP for Prucalopride: Erythro Pharma Private Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Prucalopride Drug Master Files are active?

Erythro Pharma Private Limited (DMF 39188). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Prucalopride records mean?

1 organisation has only inactive Type II DMFs for Prucalopride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Prucalopride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Prucalopride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.